• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Cost a key consideration of WHO guidelines for diabetes treatment intensification

byCaitlyn HuiandDeepti Shroff Karhade
September 6, 2018
in Chronic Disease, Endocrinology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. WHO guidelines recommend selecting sulfonylureas as the single best second-line agent for Type 2 Diabetes Mellitus (T2DM) patients.

2. Authors of a commentary on the WHO guidelines highlighted the prioritization of cost in the clinical decision-making.

Evidence Rating Level: 2 (Good)

Study Rundown: T2DM remains an increasing health concern for patients, resulting in significant morbidity in many of those affected. The World Health Organization (WHO) recently issued guidelines regarding medication selection for treatment intensification in patients with T2DM. It also addressed insulin use in patients with Type 1 or 2 Diabetes. The WHO guidelines consisted of five overall recommendations. Of note, sulfonylureas are recommended as the best second-line agent for T2DM. With respect to limitations, the authors of an accompanying commentary compared the American College of Physicians (ACP) guidelines on diabetes treatment with WHO guidelines. They reflected that the WHO guidelines prioritized cost more heavily in the recommendations of T2DM medications, due to the necessity for WHO guidelines to also apply to low-resource settings.

Click to read the study in Annals of Internal Medicine

Click to read an accompanying Editorial

Relevant Reading: The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenarios

RELATED REPORTS

2 Minute Medicine Rewind February 6, 2023

Sodium-glucose cotransporter 2 inhibitors may reduce incidence of obstructive airway disease

Metformin use in Type 2 Diabetes associated with decreased risk of joint replacement

In-Depth [clinical guidelines]: WHO developed diabetes medication guidelines targeted towards an audience of clinicians, policymakers, national diabetes program managers, and medicine procurement officers. The recommendations were synthesized through a 12-member development group, followed by a peer review from 6 external reviewers. All recommendations were based on high-quality systematic reviews and were rated with respect to recommendation strength and evidence quality. Guidelines included recommending introducing human insulin treatment to patients with T2DM that are not achieving glycemic control with metformin and/or a sulfonylurea. Further, it was suggested to consider long-acting insulin analogues in patients who have frequent severe hypoglycemia events.

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: diabetes
Previous Post

Medicare bundled payments for lower extremity joint replacements results in fewer discharges to post-acute care facilities

Next Post

Designer opioid receptor agonist provides pain relief without opioid side effects in nonhuman primates [PreClinical]

RelatedReports

Prevalence of hypertension among adolescents varies by race and BMI
Weekly Rewinds

2 Minute Medicine Rewind February 6, 2023

February 6, 2023
CPAP may not decrease cardiovascular events in sleep apnea
Endocrinology

Sodium-glucose cotransporter 2 inhibitors may reduce incidence of obstructive airway disease

February 2, 2023
Type 2 diabetes associated with reduction in disability-free life years
Chronic Disease

Metformin use in Type 2 Diabetes associated with decreased risk of joint replacement

January 16, 2023
Pediatric DKA associated with recent acute care visits
Cardiology

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

January 11, 2023
Next Post
National acute HCV infections may be underestimated

Designer opioid receptor agonist provides pain relief without opioid side effects in nonhuman primates [PreClinical]

Early language exposure is predictive of language skills and IQ in school-age children

Early language exposure is predictive of language skills and IQ in school-age children

Attenuation values may help differentiate renal neoplasm from simple cyst on contrast-enhanced CT

Addition of CT angiography to standard care for stable chest pain reduces mortality due to coronary disease

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Momelotinib reduces symptom burden compared to danazol in patients with myelofibrosis
  • Machine renal perfusion reduces delayed graft function after transplantation
  • COVID-19 mRNA vaccines are safe and effective in children aged 5 to 11 years
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options